Drug interactions that you need to know!

被引:2
作者
Voigt, N. [1 ]
Ort, K. [2 ]
Sossalla, S. [3 ]
机构
[1] Univ Med Gottingen, Mol Pharmakol, Gottingen, Germany
[2] Univ Med Gottingen, Thorax Herz & Gefasschirurg, Gottingen, Germany
[3] Univ Klinikum Regensburg, Expt & Intervent Kardiol, Regensburg, Germany
来源
PNEUMOLOGIE | 2019年 / 73卷 / 05期
关键词
Arzneimittelinteraktionen; Cytochrom P450; Polypharmazie; Pharmakokinetik; Pharmakodynamik; drug-drug interactions; cytochrome P450; polypharmacy; pharmacokinetics; pharmacodynamics; SEROTONIN REUPTAKE INHIBITORS; MECHANISMS; RISK;
D O I
10.1055/a-0863-6242
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Arzneimittelinteraktionen (AMI) sind ein haufig unterschatztes Problem der modernen Medizin. Die Zahl alterer, multimorbider Patienten, die mehrere Wirkstoffe gleichzeitig einnehmen, nimmt stetig zu - der damit verbundene exponentielle Anstieg moglicher AMI ist fast unuberschaubar. Diese ubersicht stellt haufige, relevante AMI anhand von Beispielen dar und zeigt Strategien auf, wie sie in der Praxis fruhzeitig erkannt und vermieden werden konnen. Abstract Drug-drug interactions (DDI) represent a significant problem in modern medicine. The number of patients with multi-morbidity, who take multiple drugs, is constantly increasing (polypharmacy). The related exponential increase in potential DDI is almost incomprehensible. In this article, we review pharmacodynamic DDI and provide clinically relevant examples. In addition, we extensively review pharmakokinetic DDI (e.g. through the cytochrome P450-system or p-glycoproteins) that can modify the plasma concentration of many compounds, thereby also increasing the likelihood of unwanted side effects. Finally we provide tools, which may help clinicians in their daily practice to identify and avoid potential DDI. In the context of an ageing society receiving polypharmacy, a better awareness of DDI and of strategies to prevent them is expected to reduce mortality and morbidity.
引用
收藏
页码:306 / 318
页数:13
相关论文
共 25 条
  • [1] Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy
    Abbas, Sascha
    Ihle, Peter
    Harder, Sebastian
    Schubert, Ingrid
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 912 - 922
  • [2] Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
    Agewall, Stefan
    Cattaneo, M.
    Collet, J. P.
    Andreotti, F.
    Lip, G. Y. H.
    Verheugt, F. W. A.
    Huber, K.
    Grove, E. L.
    Morais, J.
    Husted, S.
    Wassmann, S.
    Rosano, G.
    Atar, D.
    Pathak, A.
    Kjeldsen, K.
    Storey, R. F.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (23) : 1708 - +
  • [3] Changes in plasma protein binding have little clinical relevance
    Benet, LZ
    Hoener, BA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) : 115 - 121
  • [4] Drug Interactions-Principles, Examples and Clinical Consequences
    Cascorbi, Ingolf
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2012, 109 (33-34): : 546 - U33
  • [5] Cronnolly Breda, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.02.2012.5936
  • [6] Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function Mechanisms, Clinical Outcomes and Implications for Use in Elderly Patients
    de Abajo, Francisco J.
    [J]. DRUGS & AGING, 2011, 28 (05) : 345 - 367
  • [7] Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis
    Dechanont, Supinya
    Maphanta, Sirada
    Butthum, Bodin
    Kongkaew, Chuenjid
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (05) : 489 - 497
  • [8] Pharmacology of the new oral anticoagulants
    Dempfle, C. -E.
    [J]. HERZ, 2012, 37 (04) : 362 - 368
  • [9] Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation
    Drew, Barbara J.
    Ackerman, Michael J.
    Funk, Marjorie
    Gibler, W. Brian
    Kligfield, Paul
    Menon, Venu
    Philippides, George J.
    Roden, Dan M.
    Zareba, Wojciech
    [J]. CIRCULATION, 2010, 121 (08) : 1047 - 1060
  • [10] Selective serotonin reuptake inhibitors and brain hemorrhage A meta-analysis
    Hackam, Daniel G.
    Mrkobrada, Marko
    [J]. NEUROLOGY, 2012, 79 (18) : 1862 - 1865